Diane Reidy-Lagunes(@DianeReidyLagun) 's Twitter Profileg
Diane Reidy-Lagunes

@DianeReidyLagun

Tweets are my own. Podcast host. Catch me on https://t.co/D12qbyZyXy #proudNYer who❤️’s 🇲🇽🇪🇸🇺🇸

ID:2457390198

linkhttp://mskcc.org/cancerstraighttalk calendar_today22-04-2014 01:04:35

745 Tweets

1,1K Followers

732 Following

Diane Reidy-Lagunes(@DianeReidyLagun) 's Twitter Profile Photo

A recent trial for Memorial Sloan Kettering Cancer Center⁩ grabbed attention around the world. In a subset of patients with a certain genetic makeup, IV immunotherapy caused a 100% complete remission. What does it mean? For you as a patient and for science? link.chtbl.com/KW4YLFAO

account_circle
Diane Reidy-Lagunes(@DianeReidyLagun) 's Twitter Profile Photo

must be considered in our country, and well-designed clinical trials that address important QOL questions and cost help us get there. Drug pricing is unsustainable Nitya Raj

account_circle
Memorial Sloan Kettering Cancer Center(@MSKCancerCenter) 's Twitter Profile Photo

What are some ways patients and caregivers can offset the financial toxicity that may come with cancer treatment?

In an episode of 'Cancer Straight Talk from MSK', Emeline Aviki, MD, MBA shared some tips for choosing an insurance plan. link.chtbl.com/Yxboac3p

account_circle
Diane Reidy-Lagunes(@DianeReidyLagun) 's Twitter Profile Photo

Very clinically relevant! We always stop alkylators earlier than 12 months in our patients with Nitya Raj and our data suggest many continue to respond even when you stop it ! scholar.google.com/scholar?q=exce…

account_circle
Diane Reidy-Lagunes(@DianeReidyLagun) 's Twitter Profile Photo

What a proud day Memorial Sloan Kettering Cancer Center. Our next CEO! Dr. Vickers is an inspirational leader, respected clinician scientist, and admired by all. Let’s go MSK. mskcc.org/news-releases/…

account_circle
Diane Reidy-Lagunes(@DianeReidyLagun) 's Twitter Profile Photo

Thank you Thor Halfdanarson ! This trial showed that the more expensive drug is not necessarily better. We must consider quality of life and financial toxicity whenever we are choosing treatment options for our patients. Emeline Aviki, MD, MBA Fumiko Ladd Chino, MD

account_circle
Andrea Cercek(@AndreaCercek) 's Twitter Profile Photo

Very proud of our study published in NEJM. 100% clinical complete response with dostarlimab alone in mismatch repair-deficient locally advanced . No radiation or surgery! ASCO Memorial Sloan Kettering Cancer Center nejm.org/doi/full/10.10…

account_circle
Fumiko Ladd Chino, MD(@fumikochino) 's Twitter Profile Photo

: 'This idea that is the barrier between someone getting a tx vs paying to keep their lights on, it's shocking. We live in the best society, we have the most resources...yet we still have pts that are routinely falling through the cracks.'

#FinancialToxicity: 'This idea that #affordability is the barrier between someone getting a #cancer tx vs paying to keep their lights on, it's shocking. We live in the best society, we have the most resources...yet we still have pts that are routinely falling through the cracks.'
account_circle